| DOSS | distal over-shoulder strap; dioctyl sodium sulfosuccinate; docusate sodium |
|---|---|
| DSS | dengue shock syndrome; dioctyl sodium sulfosuccinate; Disability Status Scale; discrete subaortic st... |
| PSL | parasternal line; photostimulable luminescence; potassium, sodium chloride, and sodium lactate [solu... |
| SB | Bachelor of Science; Schwartz-Bartter [syndrome]; serum bilirubin; shortness of breath; sick bay; si... |
| SPS | scapuloperoneal syndrome; shoulder pain and stiffness; simple partial seizures; slow-progressive sch... |
| LMW heparin | Low Molecular Weight heparin |
|---|---|
| HEP | 1--heparin |
| HSPG | heparin sulfate proteoglycan |
| H | Heparin |
| HE | Heparin |
| 영문 | sodium | 한글 | 나트륨 |
|---|---|---|---|
| 설명 | 원자번호 11의 금속원자. 세포 외액의 가장 흔한 양이온으로서 세포 외액의 삼투압결정에 가장 중요한 역할을 함. 알도스테론(aldosterone: 콩팥위에 있는 부신에서 분비한다. 혈액내의 삼투압유지에 중요한 작용을 한다)에 의해 콩팥에서 재흡수가 촉진되며 체내 수분량을 결정하는 가장 중요한 인자. 신경세포 등의 흥분성 세포의 흥분시 세포내로 유입되어 흥분을 유발하는 중요한 기능도 가진다. |
||
| 영문 | heparin | 한글 | 헤파린 |
|---|---|---|---|
| 설명 | 혈액 응고를 막는 작용을 하는 다당류의 황산에스테르. 고등동물의 각종 조직에 널리 분포되어 있으며, 수술 후의 혈전증을 막는 데 쓴다. 혈액응고란 지혈의 한 과정으로 섬유소란 물질을 만들어 내는 과정이다. 이 섬유소는 손상된 혈관의 부위에 작용하여 여러 가지 세포들을 얽어 묶는 역할을 하여 결국 손상된 혈관에서 혈액의 소실을 막는다. 이 섬유소는 트롬빈에 의해 섬유소원에서 전환된다. 헤파린이라는 물질은 이 트롬빈을 억제하는 항트롬빈을 활성화하는 물질이다. |
||
morrhuic acid
naprylate (나프릴레이트
| heparin | <drug> Sulphated mucopolysaccharide, found in granules of mast cells, that inhibits the action of thrombin on fibrinogen by potentiating antithrombins, thereby interfering with the blood clotting cascade. Platelet factor IV will neutralise heparin. (18 Nov 1997) |
|---|---|
| heparin antagonists | Coagulant substances inhibiting the anticoagulant action of heparin. (12 Dec 1998) |
| heparin binding growth factor | <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells. Synonym: heparin binding growth factor. Acronym: FGF (18 Nov 1997) |
| heparin cofactor II | <chemical> A sulfated plasma protein with the mw of approximately 66kda. The protein is an inhibitor of thrombin in plasma that is activated by dermatan sulfate or heparin. It is a member of the serpin superfamily. Pharmacological action: serine proteinase inhibitors. Chemical name: Heparin cofactor II (12 Dec 1998) |
| heparin complement | The protein component of heparin in blood. (05 Mar 2000) |
| heparin eliminase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin-glucosamine 3-O-sulfotransferase | <enzyme> Reaction: 3'-phosphoadenylylsulfate + heparin-glucosamine = adenosine 3',5'-bisphosphate + heparin glucosamine 3-o-sulfate Registry number: EC 2.8.2.23 Synonym: glucosaminyl 3-o-sulfotransferase, d-glucosaminyl 3-o-sulfotransferase (26 Jun 1999) |
| heparin, low-molecular-weight | <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. Pharmacological action: anticoagulant, fibrinolytic agent. (12 Dec 1998) |
| heparin lyase | <enzyme> An enzyme of the isomerase class that catalyses the eliminative cleavage of polysaccharides containing 1,4-linked d-glucuronate or l-iduronate residues and 1,4-alpha-linked 2-sulfoamino-2-deoxy-6-sulfo-d-glucose residues to give oligosaccharides with terminal 4-deoxy-alpha-d-gluc-4-enuronosyl groups at their non-reducing ends. Chemical name: heparin lyase Registry number: EC 4.2.2.7 (12 Dec 1998) |
| heparin unit | The quantity of heparin required to keep 1 ml of cat's blood fluid for 24 hr at 0캜; it is equivalent approximately to 0.002 mg of pure heparin. Synonym: Howell unit. (05 Mar 2000) |
| acetosulfone sodium | 2-N-Acetylsulfamyl-4,4'-diaminodiphenylsulfone;a leprostatic administered orally. (05 Mar 2000) |
| acetrizoate sodium | Salt of 3-acetamido-2,4,6-triiobenzoic acid, a formerly used water-soluble radiographic contrast medium. (05 Mar 2000) |
| antimony sodium gluconate | <chemical> Antimony complex where the metal may exist in either the pentavalent or trivalent states. The pentavalent gluconate is used in leishmaniasis. The trivalent gluconate is most frequently used in schistosomiasis. Pharmacological action: antiprotozoal agents, schistosomicides. (12 Dec 1998) |
| antimony sodium tartrate | Na(SbO)C4H4O6;used in the treatment of schistosomiasis, and as an emetic. Synonym: sodium antimonyl tartrate. (05 Mar 2000) |
| antimony sodium thioglycollate | A compound of antimony trioxide and thioglycolic acid, used for tropical parasites. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
중외헤파린나트륨주사액1,000단위 - 새창
|
중외 |
A02104111 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액25,000단위 - 새창
|
한국메디텍 |
A20500531 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
한림헤파린나트륨주25,000단위 - 새창
|
한림제약 |
A37800521 | Heparin sodium | 전문의약품 | 급여 |
|
중외헤파린주사액 - 새창
|
중외 |
A02101541 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
신풍헤파린나트륨주25,000단위 - 새창
|
신풍제약 |
A00302871 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
|
메디텍헤파린나트륨주사액1,000단위 - 새창
|
한국메디텍 |
A20500541 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
애보트헤파린나트륨주10000단위 - 새창
|
Abbott |
W01860131 | Heparin sodium | 전문의약품 | 삭제 |
|
녹십자상아헤파린나트륨주사액 - 새창
|
녹십자 |
A35540521 | Heparin sodium | 전문의약품 | 급여 |
|
헬핀주사 - 새창
|
비씨월드제약 |
A16250811 | Heparin sodium | 전문의약품 | 삭제 | 분업예외의약품 |
|
파인주사 25000단위 - 새창
|
휴온스 |
A29551581 | Heparin sodium | 전문의약품 | 급여 | 분업예외의약품 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|